Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 187 entries
Sorted by: Best Match Show Resources per page
Evaluating the effect of integrated microfinance and health interventions: an updated review of the evidence.

Health policy and planning

Lorenzetti LMJ, Leatherman S, Flax VL.
PMID: 28453714
Health Policy Plan. 2017 Jun 01;32(5):732-756. doi: 10.1093/heapol/czw170.

BACKGROUND: Solutions delivered within firm sectoral boundaries are inadequate in achieving income security and better health for poor populations. Integrated microfinance and health interventions leverage networks of women to promote financial inclusion, build livelihoods, and safeguard against high cost...

Cite
Lorenzetti LMJ, Leatherman S, Flax VL. Evaluating the effect of integrated microfinance and health interventions: an updated review of the evidence. Health Policy Plan. 2017;32(5):732-756doi: 10.1093/heapol/czw170.
Lorenzetti, L. M. J., Leatherman, S., & Flax, V. L. (2017). Evaluating the effect of integrated microfinance and health interventions: an updated review of the evidence. Health policy and planning, 32(5), 732-756. https://doi.org/10.1093/heapol/czw170
Lorenzetti, Lara M J, et al. "Evaluating the effect of integrated microfinance and health interventions: an updated review of the evidence." Health policy and planning vol. 32,5 (2017): 732-756. doi: https://doi.org/10.1093/heapol/czw170
Lorenzetti LMJ, Leatherman S, Flax VL. Evaluating the effect of integrated microfinance and health interventions: an updated review of the evidence. Health Policy Plan. 2017 Jun 01;32(5):732-756. doi: 10.1093/heapol/czw170. PMID: 28453714.
Copy Download .nbib Format: NLM
Social Entrepreneurship: Improving Global Health.

JAMA

Lim YW, Chia A.
PMID: 27299615
JAMA. 2016 Jun 14;315(22):2393-4. doi: 10.1001/jama.2016.4400.

No abstract available.

Cite
Lim YW, Chia A. Social Entrepreneurship: Improving Global Health. JAMA. 2016;315(22):2393-4doi: 10.1001/jama.2016.4400.
Lim, Y. W., & Chia, A. (2016). Social Entrepreneurship: Improving Global Health. JAMA, 315(22), 2393-4. https://doi.org/10.1001/jama.2016.4400
Lim, Yee Wei, and Chia, Audrey. "Social Entrepreneurship: Improving Global Health." JAMA vol. 315,22 (2016): 2393-4. doi: https://doi.org/10.1001/jama.2016.4400
Lim YW, Chia A. Social Entrepreneurship: Improving Global Health. JAMA. 2016 Jun 14;315(22):2393-4. doi: 10.1001/jama.2016.4400. PMID: 27299615.
Copy Download .nbib Format: NLM
Protect funding for US earthquake early-warning system.

Nature

[No authors listed]
PMID: 28640275
Nature. 2017 Jun 21;546(7659):451-452. doi: 10.1038/nature.2017.22162.

No abstract available.

Cite
Protect funding for US earthquake early-warning system. Nature. 2017;546(7659):451-452doi: 10.1038/nature.2017.22162.
(2017). Protect funding for US earthquake early-warning system. Nature, 546(7659), 451-452. https://doi.org/10.1038/nature.2017.22162
"Protect funding for US earthquake early-warning system." Nature vol. 546,7659 (2017): 451-452. doi: https://doi.org/10.1038/nature.2017.22162
Protect funding for US earthquake early-warning system. Nature. 2017 Jun 21;546(7659):451-452. doi: 10.1038/nature.2017.22162. PMID: 28640275.
Copy Download .nbib Format: NLM
Alternatives to selling a medical school name.

Academic medicine : journal of the Association of American Medical Colleges

Walsh K.
PMID: 26506602
Acad Med. 2015 Nov;90(11):1431-2. doi: 10.1097/ACM.0000000000000926.

No abstract available.

Cite
Walsh K. Alternatives to selling a medical school name. Acad Med. 2015;90(11):1431-2doi: 10.1097/ACM.0000000000000926.
Walsh, K. (2015). Alternatives to selling a medical school name. Academic medicine : journal of the Association of American Medical Colleges, 90(11), 1431-2. https://doi.org/10.1097/ACM.0000000000000926
Walsh, Kieran. "Alternatives to selling a medical school name." Academic medicine : journal of the Association of American Medical Colleges vol. 90,11 (2015): 1431-2. doi: https://doi.org/10.1097/ACM.0000000000000926
Walsh K. Alternatives to selling a medical school name. Acad Med. 2015 Nov;90(11):1431-2. doi: 10.1097/ACM.0000000000000926. PMID: 26506602.
Copy Download .nbib Format: NLM
Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014.

BJU international

Schoenthaler M, Miernik A, Wilhelm K, Schlager D, Schoeb DS, Adams F, Dahm P, Hein S.
PMID: 26615772
BJU Int. 2016 May;117(5):787-92. doi: 10.1111/bju.13387. Epub 2015 Dec 29.

OBJECTIVES: To evaluate published trials on urolithiasis regarding level of evidence, type of sponsorship and declared conflicts of interest (COIs), and to elucidate a potential commercial impact.MATERIALS AND METHODS: We performed a systematic PubMed(®) literature search using a predefined...

Cite
Schoenthaler M, Miernik A, Wilhelm K, et al. Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU Int. 2015;117(5):787-92doi: 10.1111/bju.13387.
Schoenthaler, M., Miernik, A., Wilhelm, K., Schlager, D., Schoeb, D. S., Adams, F., Dahm, P., & Hein, S. (2016). Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU international, 117(5), 787-92. https://doi.org/10.1111/bju.13387
Schoenthaler, Martin, et al. "Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014." BJU international vol. 117,5 (2016): 787-92. doi: https://doi.org/10.1111/bju.13387
Schoenthaler M, Miernik A, Wilhelm K, Schlager D, Schoeb DS, Adams F, Dahm P, Hein S. Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU Int. 2016 May;117(5):787-92. doi: 10.1111/bju.13387. Epub 2015 Dec 29. PMID: 26615772.
Copy Download .nbib Format: NLM
HIV/AIDS funding: we still need it.

The Journal of the Association of Nurses in AIDS Care : JANAC

Sowell RL.
PMID: 9658358
J Assoc Nurses AIDS Care. 1998 Jul-Aug;9(4):19-20. doi: 10.1016/S1055-3290(98)80042-3.

No abstract available.

Cite
Sowell RL. HIV/AIDS funding: we still need it. J Assoc Nurses AIDS Care. 1998;9(4):19-20doi: 10.1016/S1055-3290(98)80042-3.
Sowell, R. L. (1998). HIV/AIDS funding: we still need it. The Journal of the Association of Nurses in AIDS Care : JANAC, 9(4), 19-20. https://doi.org/10.1016/S1055-3290(98)80042-3
Sowell, R L. "HIV/AIDS funding: we still need it." The Journal of the Association of Nurses in AIDS Care : JANAC vol. 9,4 (1998): 19-20. doi: https://doi.org/10.1016/S1055-3290(98)80042-3
Sowell RL. HIV/AIDS funding: we still need it. J Assoc Nurses AIDS Care. 1998 Jul-Aug;9(4):19-20. doi: 10.1016/S1055-3290(98)80042-3. PMID: 9658358.
Copy Download .nbib Format: NLM
FINANCIAL support of research.

Diabetes

[No authors listed]
PMID: 12979974
Diabetes. 1952 Jul-Aug;1(4):324-5. doi: 10.2337/diab.1.4.324.

No abstract available.

Cite
FINANCIAL support of research. Diabetes. 1952;1(4):324-5doi: 10.2337/diab.1.4.324.
(1952). FINANCIAL support of research. Diabetes, 1(4), 324-5. https://doi.org/10.2337/diab.1.4.324
"FINANCIAL support of research." Diabetes vol. 1,4 (1952): 324-5. doi: https://doi.org/10.2337/diab.1.4.324
FINANCIAL support of research. Diabetes. 1952 Jul-Aug;1(4):324-5. doi: 10.2337/diab.1.4.324. PMID: 12979974.
Copy Download .nbib Format: NLM
The pharmaceutical industry and continuing education.

JAMA

Cleophas TJ, Cleophas RC.
PMID: 11466088
JAMA. 2001 Jul 18;286(3):302-3; author reply 303-4.

No abstract available.

Cite
Cleophas TJ, Cleophas RC. The pharmaceutical industry and continuing education. JAMA. 2001;286(3):302-3; author reply 303-4
Cleophas, T. J., & Cleophas, R. C. (2001). The pharmaceutical industry and continuing education. JAMA, 286(3), 302-3; author reply 303-4.
Cleophas, T J, and Cleophas, R C. "The pharmaceutical industry and continuing education." JAMA vol. 286,3 (2001): 302-3; author reply 303-4.
Cleophas TJ, Cleophas RC. The pharmaceutical industry and continuing education. JAMA. 2001 Jul 18;286(3):302-3; author reply 303-4. PMID: 11466088.
Copy Download .nbib Format: NLM
[The double system of child protection: a French original].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Martins D, Girodet D.
PMID: 10941496
Arch Pediatr. 2000 Jul;7(7):773-8. doi: 10.1016/s0929-693x(00)80161-x.

France has a double system of child welfare as decreed by the law of July 1989. Social welfare is under the responsibility of the Regional Council (social services, early childhood health services, and child protection services). These type of...

Cite
Martins D, Girodet D. Le double système de protection de l'enfance: une originalité française. [The double system of child protection: a French original]. Arch Pediatr. 2000;7(7):773-8doi: 10.1016/s0929-693x(00)80161-x.
Martins, D., & Girodet, D. (2000). Le double système de protection de l'enfance: une originalité française. [The double system of child protection: a French original]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 7(7), 773-8. https://doi.org/10.1016/s0929-693x(00)80161-x
Martins, D, and Girodet, D. "Le double système de protection de l'enfance: une originalité française." [The double system of child protection: a French original]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 7,7 (2000): 773-8. doi: https://doi.org/10.1016/s0929-693x(00)80161-x
Martins D, Girodet D. Le double système de protection de l'enfance: une originalité française. [The double system of child protection: a French original]. Arch Pediatr. 2000 Jul;7(7):773-8. doi: 10.1016/s0929-693x(00)80161-x. French. PMID: 10941496.
Copy Download .nbib Format: NLM
A European perspective: common developments, differences and challenges in patient education.

Patient education and counseling

Deccache A, Aujoulat I.
PMID: 11390151
Patient Educ Couns. 2001 Jul;44(1):7-14. doi: 10.1016/s0738-3991(01)00096-9.

In May 1999, a European meeting was held in Paris on the evolution and developments of patient education. The situation in different European countries and the factors influencing the development and improvement of patient education were discussed. Five categories...

Cite
Deccache A, Aujoulat I. A European perspective: common developments, differences and challenges in patient education. Patient Educ Couns. 2001;44(1):7-14doi: 10.1016/s0738-3991(01)00096-9.
Deccache, A., & Aujoulat, I. (2001). A European perspective: common developments, differences and challenges in patient education. Patient education and counseling, 44(1), 7-14. https://doi.org/10.1016/s0738-3991(01)00096-9
Deccache, A, and Aujoulat, I. "A European perspective: common developments, differences and challenges in patient education." Patient education and counseling vol. 44,1 (2001): 7-14. doi: https://doi.org/10.1016/s0738-3991(01)00096-9
Deccache A, Aujoulat I. A European perspective: common developments, differences and challenges in patient education. Patient Educ Couns. 2001 Jul;44(1):7-14. doi: 10.1016/s0738-3991(01)00096-9. PMID: 11390151.
Copy Download .nbib Format: NLM
Federal funding shapes nursing's future.

Nursing economic$

Wakefield MK.
PMID: 9146264
Nurs Econ. 1997 Mar-Apr;15(2):110-1.

No abstract available.

Cite
Wakefield MK. Federal funding shapes nursing's future. Nurs Econ. 1997;15(2):110-1
Wakefield, M. K. (1997). Federal funding shapes nursing's future. Nursing economic$, 15(2), 110-1.
Wakefield, M K. "Federal funding shapes nursing's future." Nursing economic$ vol. 15,2 (1997): 110-1.
Wakefield MK. Federal funding shapes nursing's future. Nurs Econ. 1997 Mar-Apr;15(2):110-1. PMID: 9146264.
Copy Download .nbib Format: NLM
UK drug companies must disclose funding of patients' groups.

BMJ (Clinical research ed.)

Day M.
PMID: 16410564
BMJ. 2006 Jan 14;332(7533):69. doi: 10.1136/bmj.332.7533.69-a.

No abstract available.

Cite
Day M. UK drug companies must disclose funding of patients' groups. BMJ. 2006;332(7533):69doi: 10.1136/bmj.332.7533.69-a.
Day, M. (2006). UK drug companies must disclose funding of patients' groups. BMJ (Clinical research ed.), 332(7533), 69. https://doi.org/10.1136/bmj.332.7533.69-a
Day, Michael. "UK drug companies must disclose funding of patients' groups." BMJ (Clinical research ed.) vol. 332,7533 (2006): 69. doi: https://doi.org/10.1136/bmj.332.7533.69-a
Day M. UK drug companies must disclose funding of patients' groups. BMJ. 2006 Jan 14;332(7533):69. doi: 10.1136/bmj.332.7533.69-a. PMID: 16410564; PMCID: PMC1326960.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 187 entries